What is the current Muscle-on-a-Chip market size?

The Muscle-on-a-Chip market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Muscle-on-a-Chip market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driving future outlook.

What challenges does the Muscle-on-a-Chip market face?

High development costs and regulatory hurdles are significant challenges for the Muscle-on-a-Chip market.

Which regions are leading the Muscle-on-a-Chip market?

North America and Europe are currently the leading regions in the Muscle-on-a-Chip market size.

Who are the top companies in the Muscle-on-a-Chip market?

Top companies include industry leaders in biotechnology and pharmaceuticals, driving innovation and growth.

What future opportunities exist in the Muscle-on-a-Chip market?

Emerging applications in drug development and tissue engineering present significant future opportunities.

How is technology impacting the Muscle-on-a-Chip market?

Advances in microfluidics and biomaterials are significantly impacting the Muscle-on-a-Chip market and its future outlook.

What is the current regulatory landscape for the Muscle-on-a-Chip market?

The regulatory landscape is evolving, with ongoing efforts to establish clear guidelines and standards.

How will the Muscle-on-a-Chip market size change in the next 5 years?

The market size is expected to increase significantly, driven by growing demand and technological advancements.

Muscle-on-a-Chip Market Growing at CAGR — 2026 Report

Muscle-on-a-Chip by Application (Pharmaceutical R&D, Sports Medicine, Sports Equipment Development), by Types (Skeletal Muscle, Smooth Muscle, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 154

Forecast Period: 2026 - 2033

Market Size: $291 million

CAGR: 26.1%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 154

Forecast Period: 2026 - 2033

Market Size: $291 million

CAGR: 26.1%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Muscle-on-a-Chip Market Size | CAGR 26.1% Forecast 2033

Muscle-on-a-Chip Market Growing at CAGR — 2026 Report

🏭 Healthcare🌍 Global

Pages: 154

Forecast Period: 2026 - 2033

Market Size: $291 million

CAGR: 26.1%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 154

Forecast Period: 2026 - 2033

Market Size: $291 million

CAGR: 26.1%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Muscle-on-a-Chip Market Overview

The Muscle-on-a-Chip market refers to a microphysiological system that mimics the structure and function of muscle tissue, holding significant relevance in the fields of pharmaceutical research, tissue engineering, and personalized medicine. As the Muscle-on-a-Chip market size is expected to witness substantial growth, driven by its growth outlook and market forecast, industry stakeholders are keenly observing the industry expansion. The current Muscle-on-a-Chip market size is approximately $12.8 million, with a projected CAGR of 23.5% from 2026 to 2033. Key forces shaping the industry include technology shifts towards more advanced microfluidics and biomaterials, stringent regulations governing the use of animal models, and evolving consumer behavior demanding more personalized and effective treatments.

Loading chart…

The largest region in the Muscle-on-a-Chip market is North America, driven by the presence of prominent research institutions and pharmaceutical companies. The fastest-growing region is expected to be Asia-Pacific, fueled by increasing investments in biotechnology and medical research. As the market continues to evolve, driven by competitive intensity and supply-chain dynamics, stakeholders must remain attuned to these trends to capitalize on emerging opportunities and navigate the complex landscape of the Muscle-on-a-Chip industry.

Report Overview

Report Attribute	Details
Market size value in 2025	291.00 million
Revenue forecast in 2033	507.52 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Emulate; CN Bio; TissUse; Axion Biosystems; Nortis; BioIVT; InSphero; Mimetas; Ascendance Biotechnology; StemoniX; Tara Biosystems; BGI Genomics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Muscle-on-a-Chip market is poised for significant growth, driven by advancements in technology and increasing demand for innovative solutions. The Muscle-on-a-Chip market size is expected to expand rapidly, with a promising growth forecast.

Growth Drivers2 items

Advances in microfabrication and biomaterials are enabling the development of more sophisticated Muscle-on-a-Chip systems, driving growth and innovation in the market.

The increasing adoption of personalized medicine and the need for more accurate and efficient drug testing are fueling demand for Muscle-on-a-Chip solutions, contributing to the market's growth forecast.

Restraints2 items

High development costs and the need for significant investment in research and development are limiting the entry of new players into the Muscle-on-a-Chip market, potentially hindering its growth forecast.

Complex regulatory frameworks and the need for standardized testing protocols are creating challenges for companies operating in the Muscle-on-a-Chip market, affecting the overall Muscle-on-a-Chip market size.

Opportunities2 items

The integration of artificial intelligence and machine learning technologies is expected to enhance the capabilities of Muscle-on-a-Chip systems, creating new opportunities for growth and innovation in the market.

The increasing focus on regenerative medicine and tissue engineering is driving demand for Muscle-on-a-Chip solutions, offering opportunities for companies to expand their product offerings and increase their share of the Muscle-on-a-Chip market size.

Challenges2 items

The need for standardization and interoperability in Muscle-on-a-Chip systems is a significant challenge, as it requires collaboration and agreement among industry players, regulators, and researchers.

The potential cybersecurity risks associated with the use of connected and autonomous Muscle-on-a-Chip systems pose a challenge to companies operating in the market, highlighting the need for robust security measures to protect sensitive data and ensure the integrity of the Muscle-on-a-Chip market.

Market Segmentation

Loading chart…

The Muscle-on-a-Chip market can be segmented based on its application, which includes in vitro testing, drug discovery, and personalized medicine. Each application contributes to the overall market size, with in vitro testing being the largest segment. This is due to the increasing demand for alternative methods to animal testing, driving the growth of the Muscle-on-a-Chip market. Understanding the Muscle-on-a-Chip segmentation is crucial for industry players to identify opportunities and trends in the market.

The types of Muscle-on-a-Chip can be further divided into subtypes, including skeletal muscle, cardiac muscle, and smooth muscle. These subtypes have different applications and requirements, contributing to the overall market size. For instance, skeletal muscle-on-a-chip is used for in vitro testing of muscle-related diseases, while cardiac muscle-on-a-chip is used for testing cardiac-related diseases. The market taxonomy of Muscle-on-a-Chip is complex, and understanding these subtypes is essential for industry players to develop targeted strategies.

Muscle-on-a-Chip Segmentation Breakdown8 items

Application

Pharmaceutical R&D

Sports Medicine

Sports Equipment Development

Types

Skeletal Muscle

Smooth Muscle

Other

Regional Insights

Loading chart…

The Muscle-on-a-Chip market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing investments in research and development, favorable government policies, and a growing demand for innovative medical technologies.

Key drivers for North America include a strong ecosystem maturity, high adoption rates of new technologies, and significant investments in the healthcare sector. In Europe, drivers include a favorable regulatory environment, a highly developed infrastructure, and a growing focus on personalized medicine. Asia Pacific is driven by a large and growing population, increasing investments in research and development, and a rising demand for innovative medical technologies. Latin America is driven by a growing middle class, increasing investments in healthcare infrastructure, and a rising awareness of the benefits of Muscle-on-a-Chip technology. The Middle East and Africa are driven by a growing demand for innovative medical technologies, increasing investments in healthcare infrastructure, and a rising focus on research and development.

The regional forecast indicates that the Muscle-on-a-Chip market will experience significant growth in the coming years, driven by increasing demand for innovative medical technologies, favorable government policies, and growing investments in research and development. The regional analysis highlights the importance of understanding the unique drivers and challenges of each region to capitalize on the growth opportunities in the Muscle-on-a-Chip market.

Competitive Landscape

The Muscle-on-a-Chip market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Muscle-on-a-Chip competitive landscape is driven by the need for continuous innovation and differentiation, with key players focusing on developing unique technologies and service models to stay ahead. Global players have an advantage in terms of economies of scale and distribution networks, but local companies are able to compete effectively by leveraging their regional expertise and partnerships.

Companies in the Muscle-on-a-Chip market are adopting various strategies to differentiate themselves and gain a competitive edge. Common strategies include mergers and acquisitions, partnerships, product launches, expansion, R&D, and localization. However, companies face challenges such as margin pressure, compliance costs, and commoditization, which can erode their competitive advantages. To overcome these challenges, companies must focus on developing unique value propositions, investing in R&D, and building strong channel relationships.

Emulate: regional expansion

CN Bio: innovation pipeline

TissUse: premium pricing

Axion Biosystems: OEM tie-ups

Nortis: local manufacturing

BioIVT: vertical integration

Key Muscle-on-a-Chip Companies12 items

Emulate

CN Bio

TissUse

Axion Biosystems

Nortis

BioIVT

InSphero

Mimetas

Ascendance Biotechnology

StemoniX

Tara Biosystems

BGI Genomics

Market Ecosystem

The Muscle-on-a-Chip ecosystem encompasses a complex network of participants, spanning from upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly categorized into three segments: upstream, midstream, and downstream. Upstream participants provide the foundational technologies and components, while midstream integrators and channels facilitate the development and distribution of Muscle-on-a-Chip solutions. Downstream end users ultimately adopt and utilize these solutions, creating and capturing value within the ecosystem.

Technology providers — develop core technologies

Raw material/component suppliers — provide essential components

OEMs / manufacturers — produce Muscle-on-a-Chip devices

System integrators / EPCs — integrate Muscle-on-a-Chip systems

Distributors / channel partners — distribute Muscle-on-a-Chip solutions

Regulators/standards bodies — establish guidelines and standards

End users / buyers — adopt and utilize Muscle-on-a-Chip solutions

Within the Muscle-on-a-Chip ecosystem, control points and dependency risks can significantly influence adoption and value capture. Regulators and standards bodies exert control over the ecosystem by establishing guidelines and approvals, while technology providers and suppliers can create dependency risks due to input constraints. Furthermore, switching costs and interoperability requirements can impact partnerships and the overall structure of the ecosystem. As the Muscle-on-a-Chip market continues to evolve, a comprehensive value chain analysis will be essential to understanding the complex interactions and dynamics at play, particularly as the ecosystem differs by region due to varying regulatory environments and market demands.

Recent Industry Insights

The Muscle-on-a-Chip industry trends have witnessed significant developments over the last 12-18 months, shaping the future of the sector. Recent partnerships between key players have enabled the sharing of resources and expertise, driving innovation in the field. Notable mergers and acquisitions have also led to the consolidation of companies, resulting in enhanced capabilities and a more competitive landscape.

Furthermore, the launch of new products and technologies has improved the accuracy and efficiency of muscle-on-a-chip systems, addressing the growing demand for effective in vitro testing solutions. Regulatory changes have also played a crucial role, with updated guidelines and standards supporting the adoption of these systems in various applications. As a result, the Muscle-on-a-Chip market is poised for continued growth, driven by increasing investments and strategic funding rounds that are expected to propel the industry forward.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Muscle-on-a-Chip market outlook. The market exhibits high attractiveness due to its potential to revolutionize the field of muscle-related disease research and treatment. The competitive intensity is moderate, with a few key players dominating the market. The long-term outlook is positive, driven by increasing demand for personalized medicine and tissue engineering.

The innovation landscape is dynamic, with ongoing research and development in areas such as microfluidics and biomaterials. The demand-supply balance is favorable, with growing demand for Muscle-on-a-Chip devices and increasing investment in manufacturing capacity. However, key risk factors include regulatory uncertainty and technical challenges. Overall, the Muscle-on-a-Chip market outlook is promising, with opportunities for growth and innovation in the coming years.

11 items

1. Executive Summary

2. Muscle-on-a-Chip Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Muscle-on-a-Chip Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Muscle-on-a-Chip Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Pharmaceutical R&D

6.1.2. Sports Medicine

6.1.3. Sports Equipment Development

6.2. Global Muscle-on-a-Chip Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Skeletal Muscle

6.2.2. Smooth Muscle

6.2.3. Other

6.3. Global Muscle-on-a-Chip Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Muscle-on-a-Chip Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Muscle-on-a-Chip Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Muscle-on-a-Chip Market Competition by Key Manufacturers

8.1. Global Muscle-on-a-Chip Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Muscle-on-a-Chip: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Emulate

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. CN Bio

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. TissUse

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Axion Biosystems

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Nortis

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. BioIVT

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. InSphero

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Mimetas

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Ascendance Biotechnology

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. StemoniX

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Tara Biosystems

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. BGI Genomics

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Muscle-on-a-Chip Market

Figure 4: Global Muscle-on-a-Chip Market: Drivers

Figure 5: Global Muscle-on-a-Chip Market: Challenges

Figure 6: Global Muscle-on-a-Chip Market: Trends

Figure 7: Global Muscle-on-a-Chip Market: Opportunity

Figure 8: Global Muscle-on-a-Chip Market: Restraint

Figure 9: Global Muscle-on-a-Chip Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Muscle-on-a-Chip Market Value (USD Million) By Region

Figure 15: Global Muscle-on-a-Chip Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Muscle-on-a-Chip Market Value (USD Million) By Region

Figure 23: Global Muscle-on-a-Chip Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

77 items

Table 1: Market Segmentation Analysis

Table 2: Global Muscle-on-a-Chip Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Muscle-on-a-Chip Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Muscle-on-a-Chip Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Muscle-on-a-Chip Market Value (USD Million) By Region

Table 10: Global Muscle-on-a-Chip Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Muscle-on-a-Chip Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Muscle-on-a-Chip Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Muscle-on-a-Chip Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Emulate Basic Information And Sales Area

Table 31: Emulate. Products Portfolio

Table 32: CN Bio Basic Information And Sales Area

Table 33: CN Bio. Products Portfolio

Table 34: TissUse Basic Information And Sales Area

Table 35: TissUse. Products Portfolio

Table 36: Axion Biosystems Basic Information And Sales Area

Table 37: Axion Biosystems. Products Portfolio

Table 38: Nortis Basic Information And Sales Area

Table 39: Nortis. Products Portfolio

Table 40: BioIVT Basic Information And Sales Area

Table 41: BioIVT. Products Portfolio

Table 42: InSphero Basic Information And Sales Area

Table 43: InSphero. Products Portfolio

Table 44: Mimetas Basic Information And Sales Area

Table 45: Mimetas. Products Portfolio

Table 46: Ascendance Biotechnology Basic Information And Sales Area

Table 47: Ascendance Biotechnology. Products Portfolio

Table 48: StemoniX Basic Information And Sales Area

Table 49: StemoniX. Products Portfolio

Table 50: Tara Biosystems Basic Information And Sales Area

Table 51: Tara Biosystems. Products Portfolio

Table 52: BGI Genomics Basic Information And Sales Area

Table 53: BGI Genomics. Products Portfolio

Table 54: Global Market Value (USD Million) (2025-2032) By Application

Table 55: Global Market Share (%) By Application (2032)

Table 56: Global Market Value (USD Million) (2025-2032) By Types

Table 57: Global Market Share (%) By Types (2032)

Table 58: Global Muscle-on-a-Chip Market Value (USD Million) By Region

Table 59: Global Muscle-on-a-Chip Market Share (%) By Region (2025-2032)

Table 60: North America Market Value (USD Million) (2025-2032) By Country

Table 61: North America Market Value (USD Million) (2025-2032) By Application

Table 62: North America Market Value (USD Million) (2025-2032) By Types

Table 63: Europe Market Value (USD Million) (2025-2032) By Country

Table 64: Europe Market Value (USD Million) (2025-2032) By Application

Table 65: Europe Market Value (USD Million) (2025-2032) By Types

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 67: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 69: South America Market Value (USD Million) (2025-2032) By Country

Table 70: South America Market Value (USD Million) (2025-2032) By Application

Table 71: South America Market Value (USD Million) (2025-2032) By Types

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 73: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 75: Research Programs/Design For This Report

Table 76: Key Data Information From Secondary Sources

Table 77: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Muscle-on-a-Chip Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	291.00 million
Revenue forecast in 2033	507.52 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Emulate; CN Bio; TissUse; Axion Biosystems; Nortis; BioIVT; InSphero; Mimetas; Ascendance Biotechnology; StemoniX; Tara Biosystems; BGI Genomics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options